An antibiotic linked to peptides and proteins is released by electron capture dissociation fourier transform ion cyclotron resonance mass spectrometry  by Fagerquist, Clifton K et al.
An Antibiotic Linked to Peptides and Proteins
is Released by Electron Capture Dissociation
Fourier Transform Ion Cyclotron Resonance
Mass Spectrometry
Clifton K. Fagerquist
United States Department of Agriculture, Agricultural Research Service, Eastern Regional Research Center,
Wyndmoor, Pennsylvania, USA
Robert R. Hudgins, Mark R. Emmett,* Kristina Håkansson,
and Alan G. Marshall*
National High Magnetic Field Laboratory, Florida State University, Tallahassee, Florida, USA
Desfuroylceftiofur (DFC) is a bioactive -lactam antibiotic metabolite that has a free thiol
group. Previous experiments have shown release of DFC from plasma extracts after addition
of a disulfide reducing agent, suggesting that DFC may be bound to plasma and tissue proteins
through disulfide bonds. We have reacted DFC with [Arg8]-vasopressin (which has one
disulfide bond) and bovine insulin (which has three disulfide bonds) and analyzed the reaction
products by use of electron capture dissociation Fourier transform ion cyclotron resonance
mass spectrometry (ECD FT-ICR MS), which has previously shown preferential cleavage of
disulfide bonds. We observe cleavage of DFC from vasopressin and insulin during ECD,
suggesting that DFC is indeed bound to peptides and proteins through disulfide bonds.
Specifically, we observed dissociative loss of one, as well as two, DFC species during ECD of
[vasopressin  2(DFC-H)  2H]2 from a single electron capture event. Loss of two DFCs
could arise from either consecutive or simultaneous loss, but in any case implies a gas phase
disulfide exchange step. ECD of [insulin  DFC  4H]4 shows preferential dissociative loss
of DFC. Combined with HPLC, ECD FT-ICR-MS may be an efficient screening method for
detection of drug-biomolecule binding. (J Am Soc Mass Spectrom 2003, 14, 302–310) © 2003
American Society for Mass Spectrometry
Ceftiofur is a widely used broad-spectrum third-generation cephalosporin antibiotic approvedfor use to treat infections in cattle, swine, sheep,
goats, turkeys, and chickens. The four-membered ring
structure of -lactam antibiotics (which include penicil-
lins and cephalosporins) is responsible for their antimi-
crobial activity against gram-positive and gram-nega-
tive bacteria by covalently binding to, and interrupting
the function of, enzymes responsible for bacterial cell
wall synthesis. Upon intramuscular injection, ceftiofur
is rapidly metabolized (t1/2  10 min) to desfuroylceft-
iofur (DFC) through hydrolytic cleavage of its thioester
bond, generating furoic acid and a sulfhydryl moiety on
DFC (Figure 1). Previous experiments have shown
release of DFC from plasma extracts after addition of a
disulfide reducing agent, suggesting that DFC is bound
to plasma and tissue proteins at cysteine residues via
disulfide bonds [1, 2]. It is estimated that 89% of DFC is
covalently bound, through disulfide bonds, to plasma
and tissue proteins. The remaining 11% is “free” in the
form of the metabolite: Desfuroylceftiofur cysteine di-
sulfide. DFC bound to amino acids, peptides, or pro-
teins through disulfide bonds retains its antibacterial
activity because its -lactam ring remains intact.
With the advent of electrospray ionization (ESI) [3]
and matrix-assisted laser desorption/ionization (MALDI)
[4, 5] mass spectrometry, it has become relatively easy
to desorb and ionize high molecular weight biomol-
ecules into the gas phase. The higher charge states
achievable with ESI lower the m/z of high molecular
weight proteins to within the upper mass range (m/z
2000–3000) of quadrupole, ion trap, and Fourier trans-
form ion cyclotron resonance (FT-ICR) mass spectrom-
eters. The number of positive charges (protons) that can
attach to a protein depends on the number, location,
Published online March 10, 2003
Address reprint requests to Dr. C. K. Fagerquist, US Department of
Agriculture, Agricultural Research Service, Eastern Regional Research
Center, 600 E. Mermaid Lane, Wyndmoor, PA 19038, USA. E-mail:
kfagerquist@arserrc.gov
*Also at the Department of Chemistry and Biochemistry, Florida State
University, Tallahassee, FL, USA.
© 2003 American Society for Mass Spectrometry. Published by Elsevier Science Inc. Received November 11, 2002
1044-0305/03/$30.00 Revised January 15, 2003
doi:10.1016/S1044-0305(03)00063-1 Accepted January 17, 2003
and basicity of the protonation sites in the protein, the
pH of the solution, and ESI source conditions. The side
chains of basic residues (arginine, lysine and histidine)
are the most favored protonation sites [6].
A number of techniques have been developed to
dissociate multiply protonated peptides and proteins to
identify primary sequence and post-translational mod-
ifications. These techniques include: Collision-activated
dissociation (CAD) [7], infrared multiphoton dissocia-
tion (IRMPD) [8], surface induced dissociation (SID) [9],
blackbody infrared radiative dissociation (BIRD) [10],
sustained off-resonance irradiation/collision activated
dissociation (SORI-CAD) [11], and electron capture
dissociation (ECD) [12–14]. With the exception of ECD,
all of the foregoing techniques involve “ergodic” disso-
ciation mechanisms. Ergodic dissociation involves in-
creasing the internal energy of an ion via absorption of
infrared radiation or collisions with background neu-
trals or collision with a surface. The energy deposited
into an ion is randomized among all the vibrational
degrees-of-freedom. After energy redistribution, disso-
ciation occurs statistically, i.e., random localization of
energy into a vibrational mode sufficient to result in
bond rupture. The timescale for ergodic dissociation
(109–103 s) depends on the ion’s internal energy, the
number of vibrational modes, and the activation barri-
ers for bond rupture. In contrast, ECD is considered to
involve a non-ergodic/non-statistical dissociation
mechanism, i.e., fragmentation occurs on a time scale
that is much shorter (1012 s) than the time necessary
for energy randomization. ECD utilizes capture of low
energy electrons by multiply protonated peptides (or
proteins). Electrons generated from a heated filament or
dispenser cathode (either internal or external to the bore
of the magnet) react with multiply protonated peptide
or protein ions in the cell of an FT-ICR mass spectrom-
eter [12–17]. The energy from recombination is at least
4–6 eV. The mechanism of ECD is still a matter of
ongoing investigation and debate [13, 14, 18, 19]. How-
ever, regardless of the mechanism (or mechanisms)
involved, ECD produces odd-electron ions (“distonic
radical cations”) from the even-electron ions generated
by the initial ionization process.
ECD has shown unusually strong preference for the
dissociation of disulfide bonds in addition to extensive
cleavage of backbone amide bonds in peptides and
proteins. Consequently, it has rapidly been exploited in
“top-down” proteomics research because of the high
sequence coverage obtained [20, 21]. In addition, be-
cause of the non-ergodic nature of ECD, non-covalent
Figure 1. Conversion of ceftiofur to desfuroylceftiofur (an antimicrobially active metabolite).
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interactions are not affected, and thus tertiary and
quarternary structures are left intact [22–24]. ECD has
also been shown to be useful in identifying the location
of co- and post-translational modification. Ergodic dis-
sociation techniques may cause dissociative loss of
protein modifications, making it difficult to determine
the site of attachment. ECD has the advantage of
cleavage of the peptide backbone with retention of the
modification, allowing the site of the modification to be
identified [25–30].
It is well known that drugs in general, and antibiotics
in particular, often have complex and sometimes unex-
pected interactions with biomolecules beyond their
intended target. To analyze drug/target and drug/non-
target interactions, it is important to examine the nature
of the drug/biomolecule binding, i.e., covalent versus
non-covalent, reversible versus non-reversible binding.
Very recently, Haselmann et al. reported the analysis of
a non-covalently bound complex of a modified glyco-
peptide antibiotic with its target peptide using ECD
FT-ICR MS [31]. Here, we seek to exploit ECD’s prefer-
ence for cleavage of disulfide bonds as a method to
detect DFC attachment to peptides and proteins
through disulfide bonds. We also discuss the feasibility
of combining ECD FT-ICR MS with high performance
liquid chromatography (HPLC) as a screening tech-
nique for the detection of DFC attachment to plasma
and tissue proteins. To the best of our knowledge, the
present results constitute the first reported use of ECD
FT-ICR MS to analyze the binding of a covalently
bound drug/biomolecule complex. Portions of this
work were previously presented in abstract form [32].
Materials and Methods
Bovine insulin and [Arg8]-vasopressin (C-terminal
amide) were purchased from ICN Pharmaceuticals
(Costa Mesa, CA). Ceftiofur was graciously provided by
Rex Hornish (Pharmacia Animal Health, Kalamazoo,
MI). The reaction of ceftiofur and vasopressin was as
follows: Ceftiofur was first dissolved in methanol after
which an equal amount of water was added to generate
a 2  104 M ceftiofur solution. 0.25 mL of a 0.02 M
solution of sodium hydroxide (pH  11–12) was then
added to 1.0 mL of the ceftiofur solution to generate
desfuruoylceftiofur (DFC) as shown in Figure 1 [33].
The mixture was allowed to react at 36–40 °C for 10–30
min in a heated sonicator or temperature controlled
water bath. The solution was then acidified with 0.3 mL
of 0.1% formic acid to reduce the pH before reacting the
ceftiofur solution with the peptide. 0.2 mg of Arg8-
vasopressin was added to the solution and reacted for
1 h at 40 °C in a temperature controlled water bath. The
final solution was then diluted 100-fold in water to
provide a working concentration and to further dilute
the salts in the sample.
The reaction of ceftiofur and bovine insulin was as
follows. The starting solutions were: 0.17 M solution of
ammonium hydroxide (pH  10.5); 0.1% formic acid
solution (pH 3.2); 2.0 104 M solution of ceftiofur in
1:1 (MeOH:H2O); 1.0  10
4 M solution of insulin in
water. 1.0 mL of ceftiofur solution was reacted with 0.5
mL of NH4OH for 30 min at 40 °C in a temperature-
monitored sonicator. 0.5 mL of 0.1% formic acid was
then added, lowering the pH to7. 1.0 ml of the insulin
solution was then added to this solution and allowed to
react at 40 °C for 55 min. Finally, the solution was
further acidified with formic acid until the pH was 3.2,
and then, 1.0 ml of MeOH was added to facilitate
electrospray.
Samples were analyzed with a homebuilt, passively
shielded, 9.4 tesla FT-ICR mass spectrometer [34]. Sam-
ples were introduced into the mass spectrometer by a
direct infusion microelectrospray source [35] using a
syringe pump (Harvard Apparatus, Inc., Holliston,
MA) operated at 400 nL/min. 2 kV was applied be-
tween the microspray emitter and the heated capillary
entrance. The magnitude of the parent ions of interest
were increased by mass-selective external ion accumu-
lation employing a quadrupole mass filter [36]. A finer
isolation was achieved by stored waveform inverse
Fourier transform (SWIFT) mass-selective ion ejection
[37]. The isolated ions were then irradiated with low
energy electrons for 50 ms. An indirectly-heated elec-
tron dispenser cathode (10 mm diameter, no. 1109,
Heatwave, Watsonville, CA) was used for electron
irradiation [15–17].
Results and Discussion
ECD of [Vasopressin  2(DFC-H)  2H]2
Figure 2 shows the mass spectrum following ECD of
[vasopressin  2(DFC-H)  2H]2. A weak signal is
observed for [vasopressin  2(DFC-H)  H], corre-
sponding to H  atom ejection from the charge-reduced
species [vasopressin  2(DFC-H)  2H] . (Note that
the native structure of vasopressin is cyclic, and a
hydrogen is lost from each DFC on forming a DFC/
vasopressin disulfide bond. The charge of the ion re-
sults from addition of one or two protons. For example,
the mass of [vasopressin  2(DFC-H)  2H]2 is the
mass of vasopressin plus the mass of two DFC mole-
cules minus the mass of two hydrogen atoms plus the
mass of two protons.) The signal from [vasopressin 
2(DFC-H) 2H]  is also weak. The low abundances of
these species may reflect their instability given the
amount of internal energy deposited into the molecule
during the recombination process. The most abundant
fragment ions in Figure 2 correspond to -lactam ring
cleavage (m/z 1700) and dissociative loss of one DFC,
but without its thiyl sulfur (m/z 1544). These fragmen-
tations are schematically shown in Figure 3 and could
originate from dissociative losses from either [vasopres-
sin 2(DFC-H) 2H]  or [vasopressin 2(DFC-H)
H]. Based on accurate mass measurement, we have
tentatively identified the peak at m/z 1910 as dissocia-
tive loss of a methoxy group from [vasopressin 
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2(DFC-H)  2H], presumably from the imino-me-
thoxy group of DFC. That fragmentation is also sche-
matically shown in Figure 3. Figure 2 also shows a peak
at m/z 1513 (insert) which is the result of either loss of
428 (i.e., DFC-H) from [vasopressin  2(DFC-H) 
2H] or loss of 427 (i.e., DFC-2H) from [vasopressin 
2(DFC-H)H]. A weak peak at m/z 1512 (insert) is the
result of either loss of 429 (i.e., DFC) from [vasopressin
 2(DFC-H)  2H] or loss of 428 from [vasopressin 
2(DFC-H)H]. Finally, a peak at m/z 1084 is the result
of either loss of 857 [i.e., DFC  (DFC-H)] from [vaso-
pressin  2(DFC-H)  2H]  or loss of 856 [i.e.,
2(DFC-H)] from [vasopressin  2(DFC-H)  H]. Ei-
ther corresponds to loss of two DFC species from a
single electron capture event. The peak at m/z 1084 is
presumably the regenerated native cyclic peptide struc-
ture of vasopressin (see below).
Sites of Protonation of [Vasopressin  2(DFC-H)
 2H]2
To our knowledge, there are no measurements of the
gas-phase proton affinity or gas-phase basicity of ceft-
iofur or DFC. However, the most likely protonation site
for DFC is the 2-aminothiazole functional group, whose
proton affinity (PA) is 222.4 kcal/mol [38]. In Figure 4,
we have identified the most likely protonation sites in
the [vasopressin  2(DFC-H)] complex along with their
gas phase PA’s. We find that the PA of DFC is 7.7
kcal/mol greater than the PA of the N-terminal amine.
The most likely protonation sites of [vasopressin 
2(DFC-H)  2H]2 are therefore the side-chain of the
Arg8, and either the DFC attached to Cys1 or the peptide
N-terminus. Such configurations would place protons
on the most basic sites in the complex while at the same
time minimizing the Coulomb repulsion between the
two charges.
As mentioned previously, the most abundant frag-
ment ions in Figure 2 are -lactam ring cleavage (re-
sulting in a fragment ion at m/z 1700), and dissociative
loss of a DFC minus a sulfur atom, (resulting in a
fragment ion at m/z 1544). Both fragmentation channels
are also dominant channels in the collision-induced
dissociation (CID) of [M  H] of desfuroylceftiofur
cysteine disulfide (DCCD), a biomarker of ceftiofur [39].
The loss of a methoxy group from [vasopressin 
2(DFC-H)  2H] is interesting because this dissocia-
tive loss is not observed in the CID of DCCD [39].
ECD of [Insulin  DFC  4H]4
Figure 5 shows the mass spectrum following ECD of
[insulin DFC 4H]4. (Note that the mass of [insulin
 DFC  4H]4 is the mass of insulin plus the mass of
one DFC molecule plus the mass of four protons). We
find far fewer fragmentation channels than were ob-
served from ECD of [vasopressin  2(DFC-H)  2H]2.
The isotopic distribution centered at m/z 2056 corre-
sponds to the charge-reduced [insulin  DFC  4H]3.
H  atom ejection from [insulin  DFC  4H]3 is not
observed. The isotopic distribution centered at m/z 1912
corresponds to [insulin  3H]3 and thus dissociative
Figure 2. FT-ICR mass spectrum following ECD of [Arg8-vasopressin  2(DFC-H)  2H]2.
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loss of 430 (i.e., a DFC and an H atom). No doubly
charged ions are observed.
Sites of Protonation of [Insulin  DFC  4H]4
Bovine insulin is a two-chain (A and B) protein with
four basic residues: Two histidines, one lysine, and one
arginine, all located on the B-chain. Two disulfide
bonds connect the A and B chains. The A-chain has one
intrachain disulfide bond. Figure 6 shows one possible
configuration for [insulinDFC] (the gas phase PA’s of
the 2-aminothiazole group of DFC and the four basic
residues are also shown), however, one cannot deter-
mine with complete certainty the protonation sites (or
even the site of DFC attachment for [insulin  DFC 
4H]4). Although the 2-aminothiazole group of DFC
has a PA that is less than that of the side-chains of basic
residues, it is possible that DFC could be protonated if
it reduced the Coulomb repulsion that might occur if all
four protons were located on the B-chain.
Bond Cleavage by ECD
It is interesting to note that there is no significant
peptide backbone cleavage observed in the ECD
spectra of [vasopressin  2(DFC-H)  2H]2 and
[insulin  DFC  4H]4. The process which results in
efficient cleavage of disulfide bonds in these com-
plexes appears to also result in a concomitant lack of
peptide backbone cleavages (although we do observe
fragmentation of the antibiotic adducts for ECD of
[vasopressin  2(DFC-H)  2H]2). One can only
conclude that the antibiotic/peptide (and antibiotic/
Figure 3. Possible sites of cleavage for ECD of [Arg8-vasopressin  2(DFC-H) (DFC-H) 2H].
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protein) disulfide bond would appear to have a
significantly higher efficiency for cleavage than that
of the peptide backbone. Longer electron irradiation
times did not significantly alter our results. Previous
researchers have similarly noted a reduction of pep-
tide backbone cleavage in ECD spectra of peptides
and proteins that have intramolecular disulfide
bonds [13].
It is possible that use of “hot” ECD may lead to
more extensive cleavage of these antibiotic/peptide
(protein) complexes, including the peptide backbone,
and thus might give more specific information about
the positions of antibiotic attachment (assuming an-
tibiotic attachment is not completely lost). However,
in the present study, we deliberately exploit the
preference of ECD to cleave disulfide bonds to con-
firm the nature of antibiotic/peptide (protein) bind-
ing and thus, the sites of attachment, i.e., cysteine
residues. Given the facile loss of DFC from ECD of
DFC/vasopressin and DFC/insulin complexes, fu-
ture experiments might involve ECD of antibiotic/
protein complexes for larger proteins, e.g., lysozyme
or bovine serum albumin. Such experiments would
have both a practical utility (a screening method for
DFC attached to larger proteins) as well as theoretical
value (what is the largest protein for which one
observes ECD dissociative loss of a covalently bound
drug adduct).
Figure 4. Chemical structure of [Arg8]-vasopressin with two DFC molecules attached via disulfide
bonds. Possible protonation sites are identified by their gas phase proton affinities.
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Conclusions
The facile loss of DFC from [vasopressin  2(DFC-H)
 2H]2 and [insulin  DFC  4H]4 when subjected
to ECD suggests that DFC is indeed bound to pro-
teins through disulfide bonds. In addition, ECD of
[vasopressin  2(DFC-H)  2H]2 may also occur by
H atom ejection followed by ergodic dissociations,
which may include a rearrangement/fragmentation
that transfers a hydrogen atom from a DFC to the
peptide [39]. However, ECD of [insulin  (DFC) 
4H]4 does not seem to occur by that mechanism
because H atom ejection is not observed. Gas-phase
disulfide exchange appears to play a partial role in the
loss of two DFCs during ECD of [vasopressin 
2(DFC-H)  2H]2, and in loss of one DFC and a
hydrogen atom (loss of 430) from ECD of [insulin 
DFC  4H]4.
It has been documented that the binding of DFC to
plasma and tissue proteins extends the half-life of the
antibiotic [40]. In consequence, much of the residual
ceftiofur is in the form of protein-bound DFC and thus
constitutes an antibiotic residue. The facile loss of DFC
from vasopressin/DFC and insulin/DFC suggests that,
if coupled with HPLC, ECD FT-ICR MS may prove to
be a valuable technique for the detection of DFC at-
tached to proteins. In contrast to current methods,
which require chemical modifications/derivatizations
prior to analysis [1, 2], the present technique is sensi-
tive, accurate, and requires less chemical manipulations
that can lead to additional sample loss.
Figure 5. FT-ICR mass spectrum following ECD of [insulin  DFC  4H]4.
Figure 6. Primary sequence of bovine insulin with one DFC attached via a disulfide bond. Possible
protonation sites are identified by their gas phase proton affinities.
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